ArticleOncology research2026

Excellent Survival Outcome in a Patient Receiving NALIRIFOX for Metastatic Pancreatic Adenocarcinoma: A Case Report.

Abdullah Esmail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.